How to buy CardieX (CDX) shares
Learn how to easily invest in CardieX shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
CardieX Limited is a medical devices business based in Australia. CardieX shares (CDX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. CardieX has a trailing 12-month revenue of around $5.5 million. If you're looking to buy shares, check out the steps below.
How to buy shares in CardieX
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for CardieX. Find the share by name or ticker symbol: CDX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CardieX reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of CardieX. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
CardieX stock price (ASX:CDX)Use our graph to track the performance of CDX stocks over time.
CardieX shares at a glance
|52-week range||$0.049 - $0.115|
|50-day moving average||$0.0644|
|200-day moving average||$0.0697|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.006|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy CardieX stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
CardieX price performance over time
|1 week (2021-11-26)||-5.66%|
|1 month (2021-11-04)||-20.63%|
|3 months (2021-09-03)||-26.47%|
|6 months (2021-06-04)||-39.02%|
|1 year (2020-12-04)||-3.85%|
|2 years (2019-12-04)||85.19%|
|3 years (2018-12-03)||51.52%|
|5 years (2016-12-02)||-17.08%|
|Revenue TTM||$5.5 million|
|Gross profit TTM||$4.6 million|
|Return on assets TTM||-28.06%|
|Return on equity TTM||-80.43%|
|Market capitalisation||$51.3 million|
TTM: trailing 12 months
CardieX share dividends
We're not expecting CardieX to pay a dividend over the next 12 months.
CardieX share price volatility
Over the last 12 months, CardieX's shares have ranged in value from as little as $0.049 up to $0.115. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while CardieX's is 1.9503. This would suggest that CardieX's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes XCEL and Oscar 2 medical devices for the management and diagnosis of hypertension, cardiovascular disease, and other related vascular disorders. It also develops and markets home health devices, wearables, and consumer and medical health apps under the CONNEQT name. In addition, the company provides medical devices for measuring arterial stiffness and central blood pressure waveforms. It serves hospitals, clinics, research institutions and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
Stocks similar to CardieX
CardieX in the news
CardieX : Application for quotation of securities - CDX
Application for quotation of securities - CDX
Frequently asked questions
More guides on Finder
Travel insurance & COVID: How will Omicron impact my policy?
Find out what is and isn’t covered by insurance if Omicron impacts your travel plans.
How to invest in the Allup Silica IPO
Everything we know about the Allup Silica IPO, plus information on how to buy in.
The best products to achieve the clean beauty look
From where the no-makeup makeup look meets the model off duty vibe, we've put together a range of no-fuss products you'll love.
Where to watch Moulin Rouge! online in Australia
Every man wanted her – 1 man dared to love her.
How to watch Man United vs Arsenal Premier League live and match preview
Manchester United are scrambling to stay in touch with the top 4 as they host Arsenal this week
12-day advent calendars you can still get before Christmas
From toys to socks to beauty items, these are the top 12-day advent calendars you can still enjoy in the lead up to Christmas.
McDonald’s (MCD) share price, company profile and news
Steps to owning and managing McDonald's shares from in Australia.
Reputation & Christmas parties: Why I won’t be having a festive celebration this year
Reputation + Christmas parties: could it be the potential volcano erupting leaving rands, families and individuals to deal with the fallout?
Pay-as-you-groan: On-demand insurance that pays you $2K for a broken arm
Insurtech Flip has shaken up the insurance industry by launching the first on-demand injury cover in the country.
Ask an Expert